Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in Exp Gerontol

Retrieve available abstracts of 41 articles:
HTML format



Single Articles


    July 2022
  1. AKUSHEVICH I, Yashkin AP, Kravchenko J, Kertai MD, et al
    Extended anesthesia exposure for abdominal and pelvic procedures in older adults with colorectal cancer: Associations with chart dementia diagnoses.
    Exp Gerontol. 2022;164:111830.
    PubMed     Abstract available


    May 2022
  2. REISS AB, Ahmed S, Dayaramani C, Glass AD, et al
    The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.
    Exp Gerontol. 2022 May 1:111828. doi: 10.1016/j.exger.2022.111828.
    PubMed     Abstract available


    April 2022
  3. BAZRGAR M, Khodabakhsh P, Dargahi L, Mohagheghi F, et al
    MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid betaeta oligomer induced Alzheimer's like rat model.
    Exp Gerontol. 2022;164:111812.
    PubMed     Abstract available


    January 2022
  4. GLASMAN P, Houot M, Migliaccio R, Bombois S, et al
    Subtle postoperative cognitive disorder in preclinical Alzheimer's disease.
    Exp Gerontol. 2022 Jan 29:111715. doi: 10.1016/j.exger.2022.111715.
    PubMed     Abstract available


  5. TARBALI S, Zahmatkesh M, Torkaman-Boutorabi A, Khodagholi F, et al
    Assessment of lipophilic fluorescence products in beta-amyloid-induced cognitive decline: A parallel track in hippocampus, CSF, plasma and erythrocytes.
    Exp Gerontol. 2022;157:111645.
    PubMed     Abstract available


    August 2021
  6. LI P, Wu Q, Li X, Hu B, et al
    Shenqi Yizhi Granule attenuates Abeta1-42 induced cognitive dysfunction via inhibiting JAK2/STAT3 activated astrocyte reactivity.
    Exp Gerontol. 2021;151:111400.
    PubMed     Abstract available


    July 2021
  7. VASCONCELOS-FILHO FSL, da Rocha Oliveira LC, de Freitas TBC, de Pontes PADS, et al
    Effect of involuntary chronic physical exercise on beta-amyloid protein in experimental models of Alzheimer's disease: Systematic review and meta-analysis.
    Exp Gerontol. 2021 Jul 30:111502. doi: 10.1016/j.exger.2021.111502.
    PubMed     Abstract available


  8. VATANABE IP, Pedroso RV, Manzine PR, Chagas MHN, et al
    ADAM10: Biomarker of mild cognitive impairment but not of cognitive frailty.
    Exp Gerontol. 2021;149:111303.
    PubMed     Abstract available


    June 2021
  9. GALLO A, Pillet LE, Verpillot R
    New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids.
    Exp Gerontol. 2021;152:111452.
    PubMed     Abstract available


    May 2021
  10. CEZAR NOC, Aprahamian I, Ansai JH, de Oliveira MPB, et al
    Feasibility of reducing frailty components in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial (AD-HOMEX).
    Exp Gerontol. 2021;150:111390.
    PubMed     Abstract available


  11. LIU L, Cao J, Huang C, Yuan E, et al
    Analysis the alteration of systemic inflammation in old and young APP/PS1 mouse.
    Exp Gerontol. 2021;147:111274.
    PubMed     Abstract available


  12. YANG I, Arthur RA, Zhao L, Clark J, et al
    The oral microbiome and inflammation in mild cognitive impairment.
    Exp Gerontol. 2021;147:111273.
    PubMed     Abstract available


    April 2021
  13. TZEKAKI EE, Tsolaki M, Pantazaki AlphaA, Geromichalos G, et al
    The pleiotropic beneficial intervention of olive oil intake on the Alzheimer's disease onset via fibrinolytic system.
    Exp Gerontol. 2021 Apr 6:111344. doi: 10.1016/j.exger.2021.111344.
    PubMed     Abstract available


    March 2021
  14. XIAO QY, Ye TY, Wang XL, Han L, et al
    A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease.
    Exp Gerontol. 2021 Mar 27:111336. doi: 10.1016/j.exger.2021.111336.
    PubMed     Abstract available


  15. PINI L, Wennberg AM
    Structural imaging outcomes in subjective cognitive decline: Community vs. clinical-based samples.
    Exp Gerontol. 2021;145:111216.
    PubMed     Abstract available


    February 2021
  16. EGASHIRA R, Umezaki Y, Mizutani S, Obata T, et al
    Relationship between cerebral atrophy and number of present teeth in elderly individuals with cognitive decline.
    Exp Gerontol. 2021;144:111189.
    PubMed     Abstract available


    January 2021
  17. FERNANDEZ FX, Kaladchibachi S, Negelspach DC
    Resilience in the suprachiasmatic nucleus: Implications for aging and Alzheimer's disease.
    Exp Gerontol. 2021;147:111258.
    PubMed     Abstract available


  18. BLASKO I, Defrancesco M, Oberacher H, Loacker L, et al
    Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease.
    Exp Gerontol. 2021 Jan 28:111264. doi: 10.1016/j.exger.2021.111264.
    PubMed     Abstract available


  19. YAN T, Liu B, Wang N, Liao Z, et al
    The flavonoids of okra insulates against oxidative stress, neuroinflammation and restores BDNF levels in Abeta1-42 induced mouse model of Alzheimer's disease.
    Exp Gerontol. 2021;147:111263.
    PubMed     Abstract available


  20. SOYSAL P, Tan SG, Smith L
    A comparison of the prevalence of Fear of Falling between older patients with Lewy body dementia, Alzheimer's disease, and without dementia.
    Exp Gerontol. 2021;146:111248.
    PubMed     Abstract available


  21. AL-HARRASI AM, Iqbal E, Tsamakis K, Lasek J, et al
    Motor signs in Alzheimer's disease and vascular dementia: Detection through natural language processing, co-morbid features and relationship to adverse outcomes.
    Exp Gerontol. 2021 Jan 12:111223. doi: 10.1016/j.exger.2020.111223.
    PubMed     Abstract available


    December 2020
  22. TZEKAKI EE, Papaspyropoulos A, Tsolaki M, Lazarou E, et al
    Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease.
    Exp Gerontol. 2020 Dec 5:111178. doi: 10.1016/j.exger.2020.111178.
    PubMed     Abstract available


  23. LIU Q, Lei C
    Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
    Exp Gerontol. 2020;144:111187.
    PubMed     Abstract available


  24. ZHANG J, Wang R
    Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-beta induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Exp Gerontol. 2020;144:111180.
    PubMed     Abstract available


  25. SCHIMIDT HL, Carrazoni GS, Garcia A, Izquierdo I, et al
    Strength training or green tea prevent memory deficits in a beta-amyloid peptide-mediated Alzheimer's disease model.
    Exp Gerontol. 2020;143:111186.
    PubMed     Abstract available


    September 2020
  26. YADAV J, Verma AK, Garg RK, Ahmad K, et al
    Sialic acid associated with oxidative stress and total antioxidant capacity (TAC) expression level as a predictive indicator in moderate to severe Alzheimer's disease.
    Exp Gerontol. 2020 Sep 26:111092. doi: 10.1016/j.exger.2020.111092.
    PubMed     Abstract available


    August 2020
  27. WANG R, Zhang J
    Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Abeta-induced neurotoxicity by regulating JAK2.
    Exp Gerontol. 2020 Aug 29:111080. doi: 10.1016/j.exger.2020.111080.
    PubMed     Abstract available


    June 2020
  28. FERNANDES A, Tabuas-Pereira M, Duro D, Lima M, et al
    C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer's disease dementia.
    Exp Gerontol. 2020 Jun 16:111004. doi: 10.1016/j.exger.2020.111004.
    PubMed     Abstract available


    April 2020
  29. KIM YJ, Kim SH, Park Y, Park J, et al
    miR-16-5p is upregulated by amyloid beta deposition in Alzheimer's disease models and induces neuronal cell apoptosis through direct targeting and suppression of BCL-2.
    Exp Gerontol. 2020 Apr 19:110954. doi: 10.1016/j.exger.2020.110954.
    PubMed     Abstract available


  30. MUNDO IG, Vielma NMP, Lopez MG, Fleury A, et al
    DNA methylation of the RE-1 silencing transcription factor in peripheral blood mononuclear cells and gene expression of antioxidant enzyme in patients with late-onset Alzheimer disease.
    Exp Gerontol. 2020 Apr 16:110951. doi: 10.1016/j.exger.2020.110951.
    PubMed     Abstract available


  31. SCARABINO D, Peconi M, Broggio E, Gambina G, et al
    Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease.
    Exp Gerontol. 2020;136:110945.
    PubMed     Abstract available


  32. DE OLIVEIRA SILVA F, Ferreira JV, Placido J, Chagas D, et al
    Corrigendum to "Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: A cross-sectional study" [Exp. Gerontol. 131 (2020) 110816].
    Exp Gerontol. 2020 Apr 8:110943. doi: 10.1016/j.exger.2020.110943.
    PubMed    


  33. ELSWORTHY RJ, Aldred S
    The effect of age and obesity on platelet amyloid precursor protein processing and plasma markers of oxidative stress and inflammation.
    Exp Gerontol. 2020;132:110838.
    PubMed     Abstract available


    March 2020
  34. MOREL E, Armand S, Assal F, Allali G, et al
    Parkinsonian gait in aging: A feature of Alzheimer's pathology?
    Exp Gerontol. 2020 Mar 2:110905. doi: 10.1016/j.exger.2020.110905.
    PubMed     Abstract available


    February 2020
  35. SINGULANI MP, Pereira CPM, Ferreira AFF, Garcia PC, et al
    Impairment of PGC-1alpha-mediated mitochondrial biogenesis precedes mitochondrial dysfunction and Alzheimer's pathology in the 3xTg mouse model of Alzheimer's disease.
    Exp Gerontol. 2020 Feb 18:110882. doi: 10.1016/j.exger.2020.110882.
    PubMed     Abstract available


  36. YAN T, Nian T, Wu B, Xiao F, et al
    Okra polysaccharides can reverse the metabolic disorder induced by high-fat diet and cognitive function injury in Abeta1-42 mice.
    Exp Gerontol. 2020;130:110802.
    PubMed     Abstract available


  37. LIN X, Chen Y, Zhang P, Chen G, et al
    The potential mechanism of postoperative cognitive dysfunction in older people.
    Exp Gerontol. 2020;130:110791.
    PubMed     Abstract available


    December 2019
  38. ZHAO J, Liu P, Hua L, Yang X, et al
    Haplotype analysis on association between variants of interleukin 6 (IL-6) and late-onset Alzheimer's disease in a Chinese Han population.
    Exp Gerontol. 2019 Dec 21:110813. doi: 10.1016/j.exger.2019.110813.
    PubMed     Abstract available


  39. DE OLIVEIRA SILVA F, Ferreira JV, Placido J, Chagas D, et al
    Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: A cross-sectional study.
    Exp Gerontol. 2019 Dec 17:110816. doi: 10.1016/j.exger.2019.110816.
    PubMed     Abstract available


  40. CAO F, Liu Z, Sun G
    Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-beta induced neurotoxicity by targeting PTEN.
    Exp Gerontol. 2019;130:110814.
    PubMed     Abstract available


    October 2019
  41. ARIANNA V, Sonila A, Sofia P, Alessia G, et al
    Erythrocyte membrane fluidity in mild cognitive impairment and Alzheimer's disease patients.
    Exp Gerontol. 2019 Oct 21:110754. doi: 10.1016/j.exger.2019.110754.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: